$OREX Company News In focus: Breakout ... again 8:01

New Post Public Reply Private Reply Replies (0) Message Board

Sep 12, 2014 at 12:51 PM

$OREX Company News

In focus: Breakout ... again 8:01 p.m. May 28, 2014 - Lawrence G. McMillan
DaVita, Fresenius gain; energy firms slip 5:56 p.m. Nov. 25, 2013 - Ben Eisen
Obesity drug makers jockey for position as analysts praise Vivus 1:06 p.m. Oct. 3, 2013 - Russ Britt
Vivus falls 11% on EU drug approval update 12:07 p.m. Sept. 21, 2012 - Val Brickates Kennedy
Vivus says Europe likely to reject obesity drug 8:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen files mixed shelf for up to $150 mln 6:49 p.m. Sept. 14, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 4:43 p.m. Sept. 6, 2012 - Greg Morcroft
Orexigen soars 19% on analyst buy rating 1:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:21 p.m. Sept. 5, 2012 - MarketWatch
Orexigen weight loss study enrollment advances 8:41 a.m. Sept. 5, 2012 - MarketWatch.com
Arena jumps 12% amid takeover speculation 2:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 4:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Eisai gears up for launch of Arena's diet drug 10:32 a.m. July 30, 2012 - Val Brickates Kennedy
Vivus surges, Arena falls after diet drug OK 4:59 p.m. July 18, 2012 - Arti Patel
Arena falls 9% on FDA approval of rival diet drug 11:50 a.m. July 18, 2012 - Val Brickates Kennedy
Arena Pharmaceuticals down 8% in early trading 10:18 a.m. July 18, 2012 - Val Brickates Kennedy
Vivus up 10% on FDA approval of diet drug 10:00 a.m. July 18, 2012 - Val Brickates Kennedy
Vivus, Orexigen climb ahead of FDA decision 1:21 p.m. July 16, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:38 p.m. July 11, 2012 - MarketWatch
Orexigen has strong enrollment in Contrave study 2:42 p.m. July 11, 2012 - MarketWatch.com

Orexigen Therapeutics (OREX) Marked As A Dead Cat Bounce Stock 9:54 a.m. Today - TheStreet.com
'Fast Money' Recap: Protecting Yourself Before the Next Fed Meeting 5:00 a.m. Today - TheStreet.com
A New Nifty Fifty States Stock Index 12:46 a.m. Today - Seeking Alpha
Orexigen's Obesity Drug Contrave Approved by the FDA - Analyst Blog 4:30 p.m. Sept. 11, 2014 - Zacks.com
How Will Orexigen Therapeutics (OREX) Stock Respond to FDA's Contrave Approval? 4:10 p.m. Sept. 11, 2014 - TheStreet.com
Orexigen Therapeutics' (OREX) CEO Mike Narachi Hosts Conference Call (Transcript) 3:01 p.m. Sept. 11, 2014 - Seeking Alpha
Orexigen's Obesity Pill is Approved and Stock Falls. Don't be Surprised 1:23 p.m. Sept. 11, 2014 - TheStreet.com
FDA Approves Weight-Loss Drug 12:50 p.m. Sept. 11, 2014 - The Wall Street Journal Interactive Edition
OREX: FDA Approves New Weight-Loss Drug Contrave 10:46 a.m. Sept. 11, 2014 - InvestorPlace.com
Weak On High Volume: Orexigen Therapeutics (OREX) 10:05 a.m. Sept. 11, 2014 - TheStreet.com
Orexigen's Contrave Approved: What It Means To Arena 10:02 a.m. Sept. 11, 2014 - Seeking Alpha
FDA Approves Orexigen's Contrave For Obesity Treatment 9:22 a.m. Sept. 11, 2014 - Seeking Alpha
Orexigen Conference Call Notes 9:02 a.m. Sept. 11, 2014 - Seeking Alpha
FDA clears Contrave 7:05 a.m. Sept. 11, 2014 - Seeking Alpha
Takeda And Orexigen Announce FDA Approval of Contrave Extended-release Tablets For Chronic Weight Management 6:01 a.m. Sept. 11, 2014 - benzinga.com
9 Analyst Stocks to Buy Under $10 With Massive Upside Potential 8:37 a.m. Sept. 6, 2014 - 247WallSt.com
Orexigen Gets Weight Loss Drug Patent, May See Runup Into Approval Decision 11:46 a.m. Sept. 5, 2014 - Seeking Alpha
Credit Suisse Positive on Some Biotechs, Very Cautious on Others 11:10 a.m. Sept. 3, 2014 - 247WallSt.com
Belviq Sales Crack Critical Level 4:46 p.m. Aug. 29, 2014 - Seeking Alpha
Vivus Acquires Patent Rights To Qsymia Ingredient 1:38 p.m. Aug. 25, 2014 - Seeking Alpha

Takeda and Orexigen Announce FDA Approval of Contrave® (naltrexone HCI and bupropion HCI) Extended-release Tablets for Chronic Weight Management 7:00 a.m. Sept. 11, 2014 - PR Newswire - PRF
Orexigen Therapeutics to Host Conference Call and Webcast At 8:30 AM Eastern Time September 11, 2014 7:46 p.m. Sept. 10, 2014 - PR Newswire - PRF
Critical Alerts For Activision Blizzard, ACADIA Pharmaceuticals, Shutterstock, Lockheed Martin and Orexigen Therapeutics Released By InvestorsObserver 9:31 a.m. Sept. 3, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 8:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Critical Alerts For VoxelJet, Google, Orexigen Therapeutics, Illumina, and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences 8:40 a.m. July 31, 2014 - PR Newswire - PRF
Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 8:00 a.m. July 31, 2014 - PR Newswire - PRF
Orexigen Receives CHMP Day 180 List of Outstanding Issues 8:00 a.m. July 30, 2014 - PR Newswire - PRF
Critical Alerts For Regeneron Pharmaceuticals, Orexigen Therapeutics, News Corp, BorgWarner, and Michael Kors Released By InvestorsObserver 9:31 a.m. July 11, 2014 - PR Newswire - PRF
Health Care Sector Equities Scrutiny -- Research on OPKO Health, Orexigen Therapeutics, Perrigo, and Auxilium Pharma 7:20 a.m. June 25, 2014 - PR Newswire - PRF
Clinical Studies, Review Extensions, Appointments, and Conference Schedules - Analyst Notes on Karyopharm, Orexigen, INSYS, bluebird bio and AMAG Pharmaceuticals 6:30 a.m. June 18, 2014 - PR Newswire - PRF
Orexigen Therapeutics to Present at the Wells Fargo Securities 2014 Healthcare Conference 8:30 a.m. June 13, 2014 - PR Newswire - PRF
Critical Alerts For Apple, Orexigen Therapeutics, NextEra Energy, Family Dollar Store, and Alexion Pharmaceuticals Technology Released By InvestorsObserver 9:31 a.m. June 10, 2014 - PR Newswire - PRF
Conference Presentation Schedules, Approvals, Regulatory Updates, and Awards - Analyst Notes on St. Jude Medical, Waters, Hologic, Orexigen and USANA 6:00 a.m. June 10, 2014 - PR Newswire - PRF
Orexigen Announces June 11, 2014 PDUFA Action Date for NB32 8:00 a.m. June 2, 2014 - PR Newswire - PRF
Pre-Market Review on Top Gainers -- Research on Orexigen Therapeutics, Capstone Turbine, Magnegas, and Jumei International Holding 8:00 a.m. May 29, 2014 - PR Newswire - PRF
Milestone Payments, Clinical Trial Results, Technical Updates, and Earnings Results - Analyst Notes on Pharmacyclics, Isis, Novo Nordisk, Dr. Reddy's and Orexigen 5:10 a.m. May 29, 2014 - PR Newswire - PRF
Rejected Proposals, Earnings Results, and Financial Outlook - Analyst Notes on Allergan, Isis, Depomed, Lannett and Orexigen 7:30 a.m. May 15, 2014 - PR Newswire - PRF
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference 4:30 p.m. May 9, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wulcea Pioneers Safety in Smart Heated Apparel

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...

Ensuring Flooring Stability: Acclimation's Key Role

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Navigating the Maze of Required Minimum Distributions

Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...

Navigating Underinsured Motorist Coverage Woes

When the Rubber Hits the Road: Coverage Gaps Ever been in a fender bender and found out the other driver’s insurance barely covers a dent, let alone a serious crash? Believe me, it's no picnic. Chuck Clark from HelloNation digs into this with a deep dive on underinsured motorist coverage, or UIM for short. It's an eye-opener—especially if you're assuming your auto...

ModelBest & OpenBMB Unveil Open-Source OCR Models

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Extend Your Water Heater's Life with Anode Care

Small Component, Big Impact: The Anode Rod Picture this: You’ve got a trusty water heater keeping your showers steamy, but lurking inside is a villain called rust. Enter the unsung hero—the anode rod. It might not be glamorous, but this little piece of metal works overtime to save your tank from a watery grave. Tim Fessler and Dave Super, seasoned plumbing hotshots...

Termite Swarmers: Essential Clues and Action Steps

Understanding the Intrusive Nature of Termite Swarmers When it comes to creepy crawlies wreaking havoc on your beloved abode, termites are the stealthy troublemakers you need to keep an eye out for. Just because you catch a glimpse of them doesn't mean the damage is obvious or minimal. Spotting the Culprits: Termites vs. Ants Identifying what you're up against is the...

Lily Toxicity in Cats: Urgent Action Matters

Understanding the Severity of Lily Toxicity Ah, lilies. They might look pretty on your dining table, but if you’ve got a feline prowling around your house, these beauties could be a silent cat killer. In the animal-medicine world, this isn’t just another cautionary tale; it's a full-blown call to arms for cat owners. Dr. Ashley Wheatley, a veterinary expert out of...

HanAll F&B Pioneers New Path for Domestic Rice Noodles

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Karma Automotive Debuts High-Stakes Eximius Program

Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....